Today (2017 C.E. - 2025 C.E.)

This archive spans the years 2017 through 2025, a period marked by rapid advances in clean energy, medicine, technology, and social equity. It collects documented breakthroughs, policy wins, and scientific achievements from the present era. If you want evidence that progress is real and ongoing, this is where to look.

Empty bottles of alcohol, for article on psilocybin-assisted therapy

First-of-its-kind study reveals how psilocybin helps treat alcohol dependence

Psilocybin-assisted therapy helped 13 people who had struggled with heavy drinking reach the root of what they were drinking to escape, according to new interviews published in Psychology of Addictive Behaviors. Participants described years of self-blame and isolation quieting after their sessions, replaced by something many had never felt toward themselves: compassion. They credited the trained therapists and carefully held setting as much as the medicine itself, calling both essential to feeling safe enough to face old pain. The researchers are honest about the study’s limits, including a mostly white, higher-income participant group. Still, as Oregon and Colorado open legal pathways, these first-person accounts offer a hopeful glimpse of how psychedelic care might one day reach the communities who need healing most.

Young Asian Dermatologist is Using a Dermatoscope to Identify Worrying Cancerogenic Tissues on the Skin of a Senior Female, for article on melanoma metastasis research

Israeli researchers reach ‘breakthrough’ in fight against skin cancer

Melanoma may quietly build its own escape routes before it ever becomes dangerous, according to researchers at Tel Aviv University and Sheba Medical Center. They discovered that while the cancer is still confined to the skin’s outer layer, it releases tiny pigment-carrying vesicles called melanosomes that slip into the deeper dermis and coax lymph vessels to grow — essentially paving roads the tumor will later travel to spread. Because melanoma isn’t life-threatening until it leaves the skin, the team believes a vaccine could train the immune system to intercept those melanosomes first. With about 325,000 people diagnosed worldwide each year, this early-stage target could open a hopeful new chapter in shifting cancer treatment from reactive to preventive.